ArticleNPJ Parkinson's disease2021

Technology-based therapy-response and prognostic biomarkers in a prospective study of a de novo Parkinson's disease cohort.

Giulia Di Lazzaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.